Allurion Technologies Holdings Inc. has announced the publication of new long-term weight loss results from studies involving the Allurion Program. The findings, presented in publications, indicate that in a study of 522 patients, participants achieved an average weight loss of approximately 32 pounds at the time of balloon passage, with 95% of this weight loss maintained one year later. In a separate study involving 497 patients, the average weight loss was 14.3% of total body weight, with 86% of patients maintaining this weight loss one year after the initial treatment. These results highlight the potential of the Allurion Program in achieving and maintaining significant weight loss.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.